Sanofi SA (0O59)
LSE
78.83
+0.53 (+0.68%)
Closed
Aug 25, 2026
Day's Range
77.4479.74
52 wk Range
70.9293.50
Financial Statements - 0O59 - Sanofi SA
Revenue
46.71B▲ 5.5%
Net Income
7.85B▲ 39.7%Net Margin 16.8%
EBITDA
15.77B▲ 19.2%
Free Cash Flow
7.21B▲ 22.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 46.71B | 44.28B | 41.61B | 40.56B | 39.17B | 37.36B |
| Cost of Goods | 13.04B | 13.20B | 12.62B | 11.88B | 12.25B | 12.15B |
| Gross Profit | 33.66B | 31.08B | 28.99B | 28.67B | 26.92B | 25.21B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 9.59B | 9.46B | 9.17B | 10.92B | 9.14B | 7.89B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -3.29B | -2.20B | -2.21B | -766M | -979M | 6.22B |
| Pre Tax Income | 6.17B | 6.69B | 6.25B | 9.93B | 7.79B | 13.77B |
| Income Tax | 1.04B | 1.20B | 1.01B | 1.90B | 1.55B | 1.80B |
| Net Income | 7.85B | 5.61B | 5.43B | 8.48B | 6.27B | 12.33B |
| EPS Basic | 6.4 | 4.59 | 4.31 | 6.69 | 4.97 | 9.82 |
| EPS Diluted | 6.4 | 4.59 | 4.3 | 6.66 | 4.97 | 9.82 |
| Basic Shares Outstanding | 1.22B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B |
| Diluted Shares Outstanding | 1.22B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B |
| Ebit | 6.80B | 7.44B | 6.96B | 10.40B | 8.18B | 14.21B |
| Ebitda | 15.77B | 13.23B | 13.60B | 14.27B | 12.51B | 11.79B |
| Net Income Continuous Operations | 4.93B | 5.49B | 5.06B | 7.97B | 6.22B | 12.29B |
| Minority Interests | -38M | -58M | -36M | -113M | -56M | -36M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
